Artificial intelligence is accelerating the pace of molecular discovery, enabling researchers to generate thousands of potential drug candidates in the time traditional methods required to design only a handful. However, transforming AI-generated designs into viable therapies still depends on experimental validation. GenScript Biotech Corporation and Tamarind Bio are addressing this challenge through a strategic partnership…
Artificial intelligence is increasingly being used to address one of drug development’s biggest challenges: predicting whether promising therapies will succeed in humans. Olio Labs has announced research showing that its AI-powered preclinical platform can forecast potential clinical outcomes, including gastrointestinal side effects, cardiac toxicity, neuropsychiatric effects, and long-term weight changes, using advanced behavioral analysis of…
AI-native imaging company Cephia has appointed semiconductor and computer vision executive Mike McAuliffe as President and Chief Executive Officer, signaling a new phase of commercialization for its next-generation image sensor technology. The leadership move comes as demand grows for compact AI perception systems powering physical AI applications across robotics, automotive, drones, healthcare, satellites, and industrial…
Artificial intelligence and autonomous technologies are moving from experimental concepts into real-world systems that could reshape competitive markets, according to a new analysis from Egan-Jones Ratings Company. The report examines how advances in AI, automation, and autonomous decision-making are challenging traditional business models while creating new considerations for institutional investors, credit analysts, and enterprise risk…
The rise of generative AI search is transforming how brands are discovered online. Instead of directing users to a list of websites, AI-powered answer engines increasingly synthesize information into direct responses, making brand consistency a strategic requirement rather than simply a marketing best practice. According to creative studio della, organizations must now ensure that every…
Generative AI is continuing to reshape drug discovery as biotechnology companies use machine learning to shorten development timelines and identify novel therapeutic targets. Insilico Medicine has announced the nomination of ISM9077 as its latest preclinical candidate, an AI-designed small-molecule therapy aimed at treating multiple inflammatory eye diseases while also supporting broader research into aging and…
Enterprise software vendor Infor has appointed Yuka Kanemitsu as President and Representative Director of Infor Japan, reinforcing its leadership team as Japanese enterprises accelerate investments in cloud computing, artificial intelligence (AI), and industry-specific digital transformation initiatives. The appointment comes as organizations increasingly prioritize sector-focused enterprise platforms that combine AI, automation, and cloud technologies to modernize…
As AI workloads increasingly shift from cloud platforms to edge devices, memory bandwidth and storage efficiency have become critical constraints for deploying large language models (LLMs). At Future of Memory and Storage (FMS) 2026, Longsys unveiled a new portfolio of edge AI storage technologies designed to improve AI inference across AI agent hosts, AI PCs,…
As demand for AI infrastructure expands beyond cloud data centers into edge computing and enterprise deployments, startups developing specialized AI hardware and software platforms are attracting significant investor interest. Acrab has announced a $130 million Series B funding round to accelerate commercialization of its full-stack AI computing platform, expand its ecosystem, and advance the development…
